Stroke management Flashcards

(40 cards)

1
Q

Stroke causes

A
85% ischemic
(20% large artery atherosclerosis
25% small vessel lacunar stroke
20% cardioembolism
30% cryptogenic
5% others)

15% hemorrhagic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Ischemic stroke mechanisms

A
intracranial atherosclerosis
small artery disease
carotid plaque with emboli
carotid stenosis
aortic arch plaque
a fib
valve disease
ventricular thrombi
cardiogenic emboli
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Cardioembolic sources

A
atrial septal aneurysm
patent foramen ovale
a fib
mitral stenosis mechanical vegetation
cardiomyopathy MI
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

A fib and stroke

A

1% of population in NA and europe AF
5% of those over 65
2.5 mil Americans
1 of every 6 strokes due to AF

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

CHADS2

A
1 point:
CHF
Hypertension
Age > 75
Diabetes

2 points:
stroke, TIA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

ACA stroke symptoms

A

Leg > arm weakness
Leg > arm numbness
Abulia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

MCA stroke symptoms

A
Hemiplegia --> affect motor strip
Cortical features:
- aphasia
- neglect
- visual field deficit
- gaze deviation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Posterior circulation stroke symptoms

A
brainstem --> more nucleus/tract defects
Visual field defects
vertigo
Diplopia
Ataxia
Dysphagia
Weakness
Numbness
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Small vessel disease lacunar stroke syndrome

A
pure motor
pure sensory
mixed sensorimotor
dysarthria - clumsy
ataxia hemiparesis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Hyperacute/acute stroke treatment

A
iv-tPA
endovascular mechanical thrombectomy
aspirin
stroke unit
hemicranectomy
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Secondary stroke prevention

A
antiplatelets (aspirin, clopidogrel, ASA and dipyridimole)
anticoagulants (warfarin, NOACs)
carotid revascularization (carotid endarterectomy, carotid stent)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Tissue plasminogen activator

A

serine protease
converts plasminogen –> plasmin
fibrinolytic
only effective FDA approved treatment for acute ischemic stroke
10% bolus then infusion over 1 hour within 3 hours of symptom onset

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Antiplatelets for 2ndary stroke prevention (non-cardioembolic)

A
Aspirin
Clopidogrel slightly better than ASA
ASA + DP superior to ASA
Clopidogrel + ASA NOT indicated
ASA + DP NOT superior to clopidogrel
Do not combine anticoagulants + antiplatelets!!
Start tx as soon as possible
long-term treatment
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Hypertension control for stroke prevention

A

absolute target uncertain
benefits associated with overall reduction of 10/5 mmHg
optimal drug regimen uncertain - diuretic + ACEi?

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

European guidelines for management of hypertension

A

General:

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

TIA

A

episode of neurological deficit where symptoms resolve fully, noe vidence of loss of blood flow

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Infarction

A

injury permanent

18
Q

Penumbra

A

dysfunctional but salvageable tissue

19
Q

Carotid stenosis stroke risk

A

25% of disabling stroke within one year

20
Q

Carotid ischemic syndromes

A

unilateral weakness, numbness (contralateral)
Dysphasia if language dominant hemisphere
Amaurosis fugax: ophthalmic artery branch off carotid artery; transient monocular vision loss due to reduced blood flow to the retina

21
Q

Endarterectomy indications

A

symptomatic (strong indication)

asymptomatic - bruit detected (modest indication)

22
Q

Intra-arterial thrombolysis

A
direct local delivery of thrombolytic
lower dose/decreased systemic effects
increased rate of clot lysis
expanded time window (6 hours for MCA)
requires infrastructure/expertise
23
Q

Mechanical clot removal

A

time sensitive -

24
Q

Intracerebral hemorrhage sources

A

epidural, subdural: trauma
Subarachnoid: ruptured aneurysm
intraparenchymal - HTN
intraventricular

25
Amyloid angiopathy
deposition of beta amyloid in vessel wall lobar hemorrhages typically in elderly Common in DOwn's syndrome characteristic histology - Congo Red (birefringent rings of amyloid deposition)
26
Aneurysms
``` Saccular (berry) fusiform (sausage) arterial weakening typically at branch points: Circle of Willis common cause of subarachnoid hemorrhage ```
27
Aneurysm risk factors
thinner intima/media lack external elastica medial defects
28
Location of aneurysms
``` Ant communicating - 30% Post communicating - 25% MCA - 20% Carotid bifurcation - 8% Basilar bifurcation - 7% ```
29
Clinical presentation of subarachnoid hemorrhage
``` Sudden, severe headache neck pain from increased ICP nausea - chemical irritation photophobia loss/alteration of LOC focal neurological deficits sudden death ```
30
Pathological features of SAH
``` raised ICP, cerebral edema CN injury intracerebral hemorrhage intraventricular hemorrhage hydrocephalus ```
31
Epidemiology of SAH
incidence of aneurysm in popn ~2% 10/100,000 per year most commonly age 40-60 modest female preponderance
32
Hunt & Hess scale
1: asymptomatic/mild headache 2: severe headache/meningismus 3: drowsy, confused, mild deficit 4: stuporous, severe deficits 5: deep coma, moribund
33
SAH management
``` neurosurgical ICU airway, ventilation BP control ICP control - ventriculostomy fluid/electrolyte monitoring early aneurysm repair ```
34
SAH complications
recurrent bleeding from aneurysm - arterial pressure --> tamponade - clot stops intial bleed, then recurrent bleed can happen Vasospasm --> narrowing of blood vessels hydrocephalus seizures electrolyte abnormalities (commonly hyponatremia)
35
Unruptured aneurysm/incidental aneurysms
risk of bleeding 1-3%/year risk increased with previous history of SAH, large size, HTN, smoking, posterior fossa location repair if >5 mm
36
Cerebral A-V malformation
congenital 3 components: feeding arteries, nidus, draining veins High pressure from artery to vein with no arteriole or capillaries or venule in between Distended vein --> rupture
37
Cerebral A-V malformation clinical features
hemorrhage seizures headache focal neurology
38
Grading of cerebral A-V malformation
size location deep venous drainage
39
Cerebral AV malformation treatment
``` none microsurgical removal stereotactic radiosurgery embolization combination/multidisciplinary ```
40
Stroke mimics
``` DIIMMSSS Drug intoxication Infection Insanity conversion disorder Metabolic: hypoglycemia, renal failure, hepatic failure Migraines Syncope Seizure Structural: trauma, tumour, subdural hemorrhage ```